C9orf117 | Chromosome 9 open reading frame 117 | | | | ![](/images_static/rna_center.gif) | ![](/images/21474/54757_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
DNAI1 | Dynein, axonemal, intermediate chain 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | ![](/images/21649/ihc_cell_selected_60x60.jpg) | ![](/images/21649/50472_A_1_6_rna_selected_60x60.jpg) | Group enriched |
ENKUR | Enkurin, TRPC channel interacting protein | | | ![](/images_static/na_center.gif) | ![](/images/61503/ihc_cell_selected_60x60.jpg) | ![](/images/37594/143519_B_7_2_rna_selected_60x60.jpg) | Tissue enriched |
FAM181A | Family with sequence similarity 181, member A | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1603/5351_B_7_5_rna_selected_60x60.jpg) | Group enriched |
FHAD1 | Forkhead-associated (FHA) phosphopeptide binding domain 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54284/122605_B_3_5_rna_selected_60x60.jpg) | Group enriched |
MSLN | Mesothelin | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17172/40167_B_2_2_rna_selected_60x60.jpg) | Tissue enriched |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images/8428/ihc_cell_selected_60x60.jpg) | ![](/images/68/263_B_2_7_rna_selected_60x60.jpg) | Group enriched |
RSPH9 | Radial spoke head 9 homolog (Chlamydomonas) | Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31703/65073_B_4_7_rna_selected_60x60.jpg) | Group enriched |
SPEF1 | Sperm flagellar 1 | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50786/116476_B_1_8_rna_selected_60x60.jpg) | Group enriched |
UBXN10 | UBX domain protein 10 | | | ![](/images/28555/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28555/60606_B_9_6_rna_selected_60x60.jpg) | Group enriched |
AGR3 | Anterior gradient 3 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53942/122039_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
AK7 | Adenylate kinase 7 | Enzymes
| | ![](/images/3543/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3543/11712_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
ANKRD45 | Ankyrin repeat domain 45 | | | ![](/images/31655/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31657/141652_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ANKRD65 | Ankyrin repeat domain 65 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65720/148191_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1/128_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
ASRGL1 | Asparaginase like 1 | Enzymes Predicted membrane proteins
| | ![](/images/29725/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/29725/62799_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
C10orf115 | Chromosome 10 open reading frame 115 | | | ![](/images_static/na_center.gif) | ![](/images/40129/ihc_cell_selected_60x60.jpg) | ![](/images/40129/95455_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
C1orf222 | Chromosome 1 open reading frame 222 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29274/141705_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
C6orf52 | Chromosome 6 open reading frame 52 | | | ![](/images/51142/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51142/117747_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC113 | Coiled-coil domain containing 113 | | | | ![](/images_static/rna_center.gif) | ![](/images/40869/92935_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC181 | Coiled-coil domain containing 181 | | | | ![](/images/27189/ihc_cell_selected_60x60.jpg) | ![](/images/27189/59399_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC39 | Coiled-coil domain containing 39 | Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35364/140655_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC40 | Coiled-coil domain containing 40 | Disease related genes
| | | ![](/images/22974/ihc_cell_selected_60x60.jpg) | ![](/images/22974/49742_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD164L2 | CD164 sialomucin-like 2 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62915/142721_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CORO2B | Coronin, actin binding protein, 2B | Plasma proteins
| | ![](/images/17960/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17960/40759_A_6_7_rna_selected_60x60.jpg) | Tissue enhanced |
CRISP3 | Cysteine-rich secretory protein 3 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54392/121419_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
DEFB124 | Defensin, beta 124 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/51046/ihc_cell_selected_60x60.jpg) | ![](/images/51046/119629_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
DNAH5 | Dynein, axonemal, heavy chain 5 | Disease related genes Plasma proteins
| | ![](/images/37470/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37469/73561_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
DYX1C1 | Dyslexia susceptibility 1 candidate 1 | Disease related genes
| | | ![](/images_static/rna_center.gif) | ![](/images/51048/121788_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ENO4 | Enolase family member 4 | Predicted secreted proteins
| | ![](/images/37938/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/61509/148062_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/37/267_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
EYA4 | Eyes absent homolog 4 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | ![](/images/38772/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38772/83501_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
HIST3H2BB | Histone cluster 3, H2bb | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43013/113833_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
IL5RA | Interleukin 5 receptor, alpha | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13196/29761_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
KIAA0556 | KIAA0556 | | | | ![](/images_static/rna_center.gif) | ![](/images/35090/69220_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
KIAA1211L | KIAA1211-like | | | ![](/images/61678/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51082/116658_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
KIF19 | Kinesin family member 19 | | | ![](/images/43638/if_selected_60x60.jpg) | ![](/images/43638/ihc_cell_selected_60x60.jpg) | ![](/images/43638/102872_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
LRRC6 | Leucine rich repeat containing 6 | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28058/58433_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
MAP6 | Microtubule-associated protein 6 | | | ![](/images_static/na_center.gif) | | ![](/images/15442/34823_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
MUC16 | Mucin 16, cell surface associated | Predicted membrane proteins
| | ![](/images/50015/if_selected_60x60.jpg) | ![](/images/55172/ihc_cell_selected_60x60.jpg) | ![](/images/55172/120598_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
NEK5 | NIMA-related kinase 5 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35565/76880_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
SFRP4 | Secreted frizzled-related protein 4 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9712/151862_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47612/111052_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SLC27A6 | Solute carrier family 27 (fatty acid transporter), member 6 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8987/24047_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SMIM6 | Small integral membrane protein 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65721/147243_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
SPAG17 | Sperm associated antigen 17 | | | | ![](/images_static/rna_center.gif) | ![](/images/28666/60847_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
TCTEX1D4 | Tctex1 domain containing 4 | | | ![](/images_static/na_center.gif) | ![](/images/62652/ihc_cell_selected_60x60.jpg) | ![](/images/62652/140996_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TP73 | Tumor protein p73 | Plasma proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/2514/142947_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
TTYH1 | Tweety family member 1 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23617/71435_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
WDR54 | WD repeat domain 54 | | | ![](/images/53558/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53558/145084_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |